Life Sciences and Healthcare Companies

Experience Highlights

• ​​​​​​Global pharmaceutical public company in an SEC investigation involving disclosure and related issues.

• Subsidiary of a global pharmaceutical public company in a shareholder action in the Supreme Court of New York alleging breach of contract and other claims in connection with a merger agreement.

• CEO of a life sciences public company in an SEC investigation, SEC enforcement action, DOJ investigation, internal investigation, securities class action, and shareholder derivative litigation involving the company's restatement and related financial reporting, accounting, disclosure, internal controls, and insider trading issues.

• Former executive of a biotechnology company in an investigation by SEC and DOJ, a civil investigation by the New York State AG, and in a parallel securities litigation in in connection with the company’s vaccine manufacturing.

• KloudScript, a specialty pharmacy network company, in a shareholder derivative action based on dilutive self-dealing stock transactions. 

• Multinational life sciences company in conducting an internal investigation related to potential accounting violations and “channel stuffing” reported by a whistleblower.

• Genetic testing company in negotiating settlement of whistleblower complaint investigation initiated by the Office of Inspector General.

• Extended Nursing Personnel CHHA, a New York State licensed special needs certified home health agency, as well as its owners, in a broken deal lawsuit in New York State Supreme Court, arising from a proposed M&A transaction between two home healthcare companies.

• Pharmaceutical manufacturer in a derivative action arising out the company's marketing of a medication used to treat multiple sclerosis, arthritis, and other conditions. Plaintiff voluntarily dismissed its lawsuit.

• SPAC Sponsor in response to SEC investigations regarding accounting improprieties and several litigations in connection with de-SPACed entity 180 Life Sciences Corp.